{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Towards Health","title":"#15 - The New Category: Decentralized Clinical Trials","html":"","width":"100%","height":180,"duration":2099,"description":"In this episode, we hear from our guest: Michelle Longmire, CEO & Co-Founder at Medable.\nTopics discussed:\nMichelle Longmire's Inspiration: In medical school, Longmire recognized a critical access gap in healthcare. Training at the University of New Mexico, she observed the challenges faced by underserved patients and envisioned a technological bridge to healthcare.\nFormation of Medable: The idea of Medable was shaped by Longmire's experience at Stanford and the rise of mobile technology. The aim was to create a platform that provided secure, accessible healthcare and research opportunities.\nEarly Challenges and Milestones: Winning a pitch contest provided initial funding for Medable. Key hires included experts in platform technology, mobile app development, and enterprise architecture. The first major contract with a pharma company highlighted the need for expanded capabilities.\nRole in Decentralized Clinical Trials: Longmire foresaw mobile technology as a key driver in making research consumer-scale. The focus on patient-centered research and providing better access led to the rise of decentralized clinical trials.\nVision for Clinical Trial Innovation: Longmire's vision includes leveraging AI and technology to dramatically increase the number of effective therapies tested and approved each year, addressing a wide range of diseases more efficiently.\n\n\nMichelle Longmire's Social:\nLinkedIn: https://www.linkedin.com/in/michellelongmire/\nOur sponsor for this episode is H1. H1 is on a mission to create a healthier future by democratizing access to vital healthcare expertise and information globally. They offer comprehensive insights and data, benefiting doctors, researchers, and patients alike. Their innovative solutions are pivotal in accelerating the development and distribution of life-saving treatments and ensuring equitable healthcare access.\nWebsite: https://www.h1.co/\nLinkedIn: https://www.linkedin.com/company/h1co/\nX: https://twitter.com/H1co_\nTowards Health...","thumbnail_url":"https://img.transistorcdn.com/m4Nanzscf8qC6umWnwn8wtoAaI5wjIT9K1n8lLFmzis/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzMxMDQ1LzE2NjY5/ODE0NjEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}